People in the News - News Updates
Find out the latest news about DCEG Staff: awards and recognition, hirings and promotions, and engagement at scientific conferences.
-
Erikka Loftfield was selected as an Earl Stadtman tenure-track investigator in the Metabolic Epidemiology Branch (MEB) in April 2020. Dr. Loftfield will develop an integrative research program investigating the interplay between diet, metabolism, the microbiome and genetics to advance current understanding of the relationship between diet and cancer.
-
Rashmi Sinha, Ph.D., received the Fred P. Li Impact Award for her article, “Collecting Fecal Samples for Microbiome Analyses in Epidemiology Studies,” at the annual AACR meeting in 2020.
-
Martha Linet and Annelie Landgren received the Constance L. Percy Award for Distinguished Service in recognition of their work on the Virtual Pooled Registry Cancer Linkage System.
-
Six projects were funded through the 2020 DCEG Informatics Tool Challenge, a competitive program to support innovative approaches to epidemiological methods, data collection, analysis, and other research efforts using modern technology and informatics.
-
Video recordings and slides from the 2019 Radiation Epidemiology and Dosimetry Course are available online. The course covers the fundamentals of the health effects of radiation exposure, including methods of exposure assessment, and key findings from the latest studies of medical, occupational, and environmental radiation exposures.
-
Investigators and fellows presented their research and engaged virtually at the annual scientific meeting of the American Association for Cancer Research (AACR).
-
In June 2020, Dr. Robert Hoover, Director of the Epidemiology and Biostatistics program, retired from the Division of Cancer Epidemiology and Genetics after a remarkable 48 years of service to the National Cancer Institute.
-
Meredith Shiels was selected as the 2020 DCEG recipient of the Women Scientist Advisor’s Mentoring and Leadership Award, which recognizes investigators for exceptional dedication, leadership, and tireless efforts to promote and nurture NCI women scientists at all stages of their careers.
-
In May 2020, Director Stephen Chanock welcomed staff to the Spring Town Hall meeting to talk about new developments in the Division, and to recognize accomplishments over the past six months.
-
Genomic studies, serology assay valuation, descriptive epidemiology studies, and other activities of DCEG investigators and staff in response to the COVID-19 pandemic.
-
In March 2020, Laura Beane Freeman, Ph.D., was elected to serve as a Women Scientist Advisor for a term of three years.
-
The Informatics Tool Challenge, launched in 2014, provides a unique, supplementary funding source for DCEG researchers seeking to create novel tools to enhance data collection, analysis, and other avenues of investigation. A sampling of tools that illustrate the growth and success of the Challenge are described.
-
Steven C. Moore, Ph.D., M.P.H., has built a multidisciplinary research program in the Metabolic Epidemiology Branch focused on understanding the contributions of physical activity, obesity, and diet to human cancer and overall health.
-
In February 2020, Blanche P. Alter and Robert N. Hoover were elected to the prestigious American Association of Physicians, a society of America’s leading physician-scientists.
-
Elizabeth Platz, Sc.D., Deputy Chair of the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health, spent two days at DCEG as a Visiting Scholar in December 2019. Learn more about her visit.
-
Lindsay Morton, Ph.D., has been appointed Deputy Chief of the Radiation Epidemiology Branch as of January 7, 2020.
-
Martha Linet, M.D., M.P.H., Senior Investigator and former Branch Chief in the Radiation Epidemiology Branch (REB), retired in January 2020 after 33 years of service to the National Cancer Institute.
-
Ruth A. Kleinerman, Ph.D., M.P.H., staff scientist and deputy chief in the Radiation Epidemiology Branch (REB) will retire at the end of 2019 after 40 years of service. Dr. Kleinerman is widely recognized for her work on treatment-related second cancers.